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Abstract 
Objective: Aim of this study was to evaluate application of diode laser in laparoscopic partial 
nephrectomy (LPN) and to question this technique in terms of ease of tumor excision and reduction 
of warm ischaemia time (WIT). 
Background: LPN is standard operative method for small renal masses. Benefits of LPN are 
numerous, including preserving renal function and prolonging overall survival. However, reduction 
of WIT remains main challenge in this operation. In order to shorten WIT many techniques have 
been developed with variable results. 
Patients and Methods: We performed a prospective collection and analysis of health records for 
patients who were operated between March 2011 and August 2012. Inclusion criteria were single 
tumor ≤ 4cm, predominant exophytic growth and intraparenchymal depth ≤1.5 cm, with a minimum 
distance of 5 mm from the urinary collecting system. 
Results: We have operated 17 patients. Median operative time was 170 min. In all patients, except 
two patients we had to perform hilar clamping. Median duration of WIT was 16 min. 
Pathohistological evaluation revealed clear cell renal cancer and confirmed margins negative for 
tumor in all cases. Median size of tumor was 3 cm. Median postoperative hospitalization was 5 days. 
Average follow up was 11.5 months. There were no intraoperative complications. One postoperative 
complication was noted, perirenal haematoma. 
Conclusions: Laser LPN is feasible and offers benefit of shorter WIT with effective tissue coagulation 
and hemostasis. With operative experience and technical advances WIT will be reduced or even 
eliminated and solution to some technical difficulties, such as significant smoke production, will be 
found.
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Introduction 
Renal cancer (RC) accounts for approximately 2% of all malignancies occurring in adults 
1
. 
Epidemiological studies report increasing incidence of renal cancer during the last two decades until 
recently, both worldwide and in Europe 
2
. The incidence of RC in Croatia is 9.4 per 100.000 
3
 what is 
significantly higher than the worldwide rate of 3.9 per 100.000 
4
. There are some indications that a 
recent increase in incidence together with a stage shift to more organ confined stages can be 
observed 
5
. This is partially attributable to increased frequency of diagnostic imaging, such as 
ultrasound and computed tomography. This renders higher number of small renal masses (SRM) (i.e. 
tumors < 4cm). The most profound change among the many that have occurred in the management 
of RC is current recommendation for treatment of SRMs, if possible, with nephron sparing surgery 
(NSS) 
6
. Open partial nephrectomy, the erstwhile reference standard treatment for small renal 
masses, has demonstrated no difference in either overall or cancer-specific survival compared to 
radical nephrectomy with the benefit of better preservation of renal function 
7
. Reports have 
confirmed equal oncological outcomes with laparoscopic partial nephrectomy but with advantages 
of minimally invasive surgery 
8
. However, the main challenge to reduce the morbidity associated 
with this procedure is still remaining. 
The need for hilar clamping in case of laparoscopic partial nephrectomy (LPN) is currently necessary 
to create a bloodless field for renal excision. However, hilar clamping places time constraint for the 
surgeon and increased warm ischaemia time (WIT) compromise renal function in subsequent 
postoperative period. Since none of the current operative techniques is the most effective there are 
many techniques that have been developed to achieve hemostasis, including conventional suture 
repair, tissue sealants, radiofrequency ablation, water dissection, microwave tissue coagulation and 
lasers 
9
. Different ex vivo laser assisted LPN were published 
10
. However, few in-vivo surgery series 
are available 
11
. Aim of this study was to evaluate application of diode laser in laparoscopic partial 
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nephrectomy and to question this technique in terms of ease of tumor excision and reduction of 
WIT. 
Patients and methods 
We performed a prospective collection and analysis of health records for patients who were 
operated laparoscopically with application of laser for SRMs at University Hospital Center Zagreb, 
Zagreb, Croatia, from March 2011 to August 2012. Diagnosis of SRM was based on computed 
tomography scans and/or magnetic resonance imaging. Inclusion criteria were single tumor with size 
≤ 4cm, predominant exophytic growth and intraparenchymal depth ≤1.5 cm, with a minimum 
distance of 5 mm from the urinary collecting system. R.E.N.A.L nephrometry score was used to 
describe renal mass anatomy 
12
. Exclusion criteria were ASA-score>= 3, centrally located tumor and 
(functional) single kidney. Both medical and surgical complications were recorded according to the 
modified Dindo-Clavien classification
13
. One laparoscopic surgeon (N.K.) performed all procedures. 
Surgical technique 
Conventional laparosopic lateral transperitoneal approach with 4 trocars was used in all cases. 
Firstly, renal tumor was identified and kidney fully mobilized, allowing the manipulation for 
circumferential laser resection (Figure 1). Hilar vessels were always identified. For renal resection we 
have used diode laser 980 nm (Ceralas ® HPD, Biolitec AG, Jena, Germany) with end fire 1000 µm 
laser fibre BFF-1003-dl (Biolitec AG, Jena, Germany). For last case we have used Dual diode laser 980 
and 1470 nm (Ceralas®HPD DUAL , Biolitec AG, Jena, Germany). Chromophore target for 980nm 
laser is haemoglobin and for dual laser 980/1470 nm haemoglobin/water. Laser fibre was introduced 
through 10mm trocar with special holder designed for laparoscopic application and in last case we 
have used special holder with simultaneous irrigation and suction (S064 Jet Suction Irrigator, SUS, 
Barnsley, UK). Power settings were continuous mode with power settings 20-80W. Demarcation of 
safe initial resection line around tumor was done with laser (power settings initially were 20-40W, 
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and in later cases 40-60W). We would continue with laser tumor resection with an adequate free 
resection margins in contact fashion (up to 80W) (Figure 2). At time of more significant bleeding due 
to resection of larger blood vessels we would tighten priorly placed laparoscopic tourniquet at renal 
artery. Diode laser 980nm proved to be more efficient with faster resection time in ischemic 
conditions. When tumor was resected, cellulose mesh was placed on the resection bed and fixed 
with one parenchymal suture (2-0 Vicryl) (Figure 3). Finally, tourniquet could be released without 
significant bleeding. If needed additional parenchymal sutures were placed. The tumor was removed 
using laparoscopic retrieval bag (Memo Bag, 200mL, Rüsch, Teleflex Medical). After removal, 
specimen was checked to ensure macroscopically tumor free surgical margin. Figure 4 illustrates 
representative preoperative CT images. 
Results 
We have operated 17 patients with small peripherally placed renal tumors (Table 1). All operations 
were successfully performed laparoscopically. Median operative time was 170 min (140 to 240 min). 
In all patients except two patients we had to perform hilar clamping. Median laser activity prior to 
hilar clamping was 15 min and was followed with median duration of WIT 16 min. One patient that 
did not require hilar clamping had small 2cm SRM mostly exophytic. Second patient had 3.5 cm large 
tumor which was resected with Dual diode laser. This laser system proved more effective regarding 
haemostasis, however due to excessive smoke production and thus impaired visibility this laser 
resection lasted for 40 min. Median blood loss was 70 mL (50 to 200 mL), and none of patients 
required postoperative transfusion. 
Pathohistological evaluation revealed clear cell renal cancer and confirmed margins negative for 
tumor in all cases. There were no intraoperative complications. One postoperative complication was 
noted, perirenal haematoma, which was treated conservatively (Clavien grade 2). 
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Discussion 
The present study includes a series of patients with SRMs treated effectively laparosopically and 
utilizing laser as a method of renal resection. Our series points that laparoscopic partial 
nephrectomy with laser is feasible and offers benefit of shorter WIT with more effective tissue 
coagulation, hemostasis and potential for omission of hilar clamping. 
The location, size and exophytic properties of the lesion determine potential complexity of the 
operation therefore objective characterization of renal mass anatomy facilitates treatment selection 
and prediction of surgical outcomes. R.E.N.A.L nephrometry score was developed for this purpose 
and in our series all tumors were scored 6 or less, suggesting a clear selection of patients at low risk 
for complications. 
Partial nephrectomy is the prevailing method for small sized tumors and proven to be better in 
preservation of renal function compared to radical nephrectomy 
7
. LPN is technically challenging 
procedure mainly because of the lack of reliable methods of hemostasis and requiring prolonged 
WIT. The effect of WIT on postoperative renal function is one of the central questions regarding LPN. 
Thus, new techniques are needed to abandon hilar clamping. Laser technology presents a promising 
alternative to achieve tumor excision and renal haemostasis, with or without hilar occlusion. Laser 
offers a possibility of both open and laparoscopic partial nephrectomy. 
Several experimental studies have demonstrated the efficiency of laser assisted open or 
laparoscopic partial nephrectomy in various experimental set-ups. Ogan et al. have reported first 
experiences with diode laser 980-nm laparoscopic partial nephrectomy in porcine with conclusion 
that clinical trials in humans should be limited to small exophytic tumors
14
. Up to date twelve 
research groups have published small series concerning clinically tested laser assisted open or 
laparoscopic partial nephrectomies 
11, 15-25
. Up to our knowledge this is largest published series of 
laser laparoscopic partial nephrectomy. 
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It has been reported that renal damage is proportional to the WIT with current recommendation 
that WIT should stay within 20 minutes 
26
. Lane et al. estimated a decline in GFR of 2.2 
ml/min/1.73m2 per every 5 min of WIT 
27
. It has been traditionally considered that LPN has a longer 
WIT than open partial nephrectomy. In the developmental stages of LPN, mean WIT was in the 30 
minute range. However, modifications to standard LPN techniques have helped improve WIT 
28
. In 
recently published comparative series of LPN vs. open or robotic partial nephrectomy mean WIT for 
LPN was in a range of 13.0 to 36.4 minutes 
29, 30
. Our series with a median WIT of 16 min and with 
two cases without WIT is example of this improvement. Additionally, complications of partial 
nephrectomy include hemorrhage, urinary leak, infection, formation of urinary fistula, and the 
development of renal insufficiency 
31
. 
Laser function is achieved through absorption of its energy on chromophores 
32
. Absorbed laser 
radiation is converted into heat, causing a local rise in temperature. Depending on the amount of 
heat produced, tissue will coagulate or even vaporize. Chromophores are chemical groups capable of 
absorbing light at a particular frequency and thereby imparting color to a molecule. In surgery, 
chromophores that are most often used are haemoglobin and water. Diode 980nm laser is absorbed 
on haemoglobin and we have noticed that if during kidney resection some bleeding is present it is 
inadequate in further resection. At this time we had to clamp the artery reducing bleeding and were 
able to continue with at this time even faster resection. Since dual diode 980/1470 nm laser at the 
same time is absorbed on water and haemoglobin it offers the possibility of tissue coagulation even 
if larger bleeding is present. Our experience with dual laser is limited (one case) but it proved more 
effective, faster and with better coagulation properties. However, it also produces more smoke. In 
our opinion there are several factors that can help in achieving 0 min WIT: careful patient selection 
(small and exophytic tumors) and lasers that are absorbed on water (e.g. Dual diode lasers or 
Thulium lasers). Until we achieve further clinical experience cellulose mesh and/or parenchymal 
sutures will continue to be used for larger tumors. 
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The major disadvantage of the laser is remarkable smoke production obstructing adequate visibility 
in laparoscopic surgery. There are several possibilities to deal with this situation. Slow saline 
irrigation could lower smoke production with questionable effect on laser coagulation efficiency 
33
. 
Liang et. al investigated Thulium-YAG laser and influence of several irrigation rates on coagulation 
efficiency. They reported acceptable influence on coagulation with suitable effect on smoke 
production 
34
. This might be even more acceptable in lasers with wavelength absorbed on 
haemoglobin such as diode laser 980nm. We have tested this effect in some parts of the operation. 
While it was bleeding we used water irrigation to clear resection line. However, at that time due to 
inability to utilize suction at the same time we limitedly used continuous irrigation. Second method 
to improve visibility is gas suction; however this requires capacitive insufflation system. Also this 
could require additional trocar for the assistant. However, we managed to acquire one instrument 
that can deliver laser fiber, irrigation and suction canal at the same time. We have tested it with Dual 
laser and found that while small rate of irrigation is indeed successful in reducing smoke production 
it reduces effectiveness of wavelength 1470nm therefore slowing resection and reducing 
coagulation effect. Furthermore, suction even though placed near the tip of the laser fiber did not 
adequately evacuated produced smoke while it significantly lowered pneumoperitoneum pressure.  
Currently, European Association of Urology guidelines considers that a minimal tumor free margin is 
sufficient to avoid local tumor recurrence 
6
. One possible disadvantage of laser LPN is impaired 
intraoperative visibility of resection plane due to coagulated and burned tissue what might increase 
occurrence of positive surgical margins (PSM). However, with adequate surgical technique and prior 
demarcation of resection line around the tumor one can achieve tumor free margins. Positive 
surgical margins in laparoscopic partial nephrectomy are in a range of 0.7–4% 
35
 and in our series 
none of the patients had PSM. Frozen section analysis for evaluation of resection margins during LPN 
is of minor clinical significance, as the surgeon’s gross assessment of macroscopically negative 
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margins provides reliable results 
35
. It is also notable that tissue necrosis zone after laser resection 
creates additional safety margin what may render PSM clinically insignificant. 
Study limitations include the small sample size, the lack of a control group and the short follow-up 
period. 
Conclusions 
Laparoscopic partial nephrectomy with laser is feasible and offers benefit of shorter WIT with more 
effective tissue coagulation, hemostasis and potential for omission of hilar clamping. Laser cutting 
should be performed at a small distance to the tissue with a slow velocity of fibre movement to 
achieve best cutting and coagulation properties. With operative experience and technical advances 
in laser and fibre production WIT will be reduced or even eliminated and solution to some technical 
difficulties, such as significant smoke production, will be found. LPN with laser should be attempted 
in carefully selected patients with favorable features of tumor anatomy. Further studies with longer 
follow up are needed to establish oncologic efficacy of the procedure. 
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Table 1. Summary of demographic, intraoperative and postoperative data for laser assisted 
laparascopic partial nephrectomy 
 
No. of patients 17 
Average age (years) 61.6 (41.5-75.3) 
Sex (M/F) 10/7 
Side (left/right) 9/8 
Median operative time (min) 170 (140-240) 
Median blood loss (mL) 70 (50-200) 
Median warm ischaemia time (min) 16 (9-20) 
Median hospitalization (days) 5 (5-9) 
Average follow up (months) 11.5 (1-18) 
Pathohistologic evaluation 
Clear cell renal cancer 17 
Median tumor size 3 (2-4.8) 
 
 
